Light therapy is a scientifically validated and effective treatment for sleep and circadian rhythm related disorders such as jet lag, chronic insufficient sleep and mood disorders. Light therapy treatment is currently available on a non-prescription basis and may be used across the broad spectrum of people suffering from sleep disorders to individuals who want to manage their body clock for optimal sleep quality and daytime performance.
Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers. Respironics markets its products in 141 countries and employs over 5,100 associates worldwide. Further information can be found on the Company's Web site: http://www.respironics.com.
This document contains forward-looking statements, including statements
relating to, among other things, developments in the healthcare industry;
the success of the Company's marketing, sales, and promotion programs;
future sales, acceptance, and quality of the Company's products and
programs; the results of clinical trials; the timing and success of new
product introductions; new product development; anticipated cost savings;
FDA and other regulatory requirements, enforcement actions, product recalls
or related field actions; future results from acquisitions and strategic
investments; growth rates in foreign markets; regulations and other fa
|SOURCE Respironics, Inc.|
Copyright©2007 PR Newswire.
All rights reserved